Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up
Journals
Journal of the European Academ...
Journal of the European Academy of Dermatology and Venereology : JEADV
#21
LETTER
Débora D B C Andrade, Reagan Nzundu, Rodolfo R D Rodrigues, Ricardo Romiti, Yago R T Santana, Patrícia S Kurizky, Ana P R de Lima, André Carvalho, Darren M Ashcroft, Ciro M Gomes, Christopher E M Griffiths
No abstract text is available yet for this article.
April 5, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#22
JOURNAL ARTICLE
M Spadafora, A Megna, N Lippolis, M Cavicchi, S Borsari, S Piana, S Guida, S Kaleci, J Chester, G Pellacani, C Longo
BACKGROUND: Differential diagnosis of amelanotic/hypomelanotic melanoma among solitary flat pink lesions is challenging, due to limited clinical and dermoscopic clues. Dermoscopy and reflectance confocal microscopy assessments improve diagnostic accuracy, but their combined capacity among solitary flat pink lesions is yet to be defined. OBJECTIVES: To determine (i) whether diagnostic accuracy is improved with combined dermoscopy and reflectance confocal microscopy, (ii) a model to estimate probability of flat amelanotic/hypomelanotic melanoma among solitary flat pink lesions...
April 4, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#23
LETTER
Jöri Pünchera, Hubert Vuagnat, Hans-Joachim Laubach
No abstract text is available yet for this article.
April 4, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#24
JOURNAL ARTICLE
R von Kiedrowski, T Hinz, G Mauer, A Schwinn, A Timmel, H J Hutt, M Augustin
BACKGROUND: Brodalumab, a fully human monoclonal immunoglobulin IgG2 antibody that binds the human interleukin 17 receptor subunit A, is available for the treatment of moderate-to-severe plaque psoriasis in Europe since September 2017, but so far there are only a few studies on its use in real-world conditions. OBJECTIVES: To assess the management of moderate-to-severe psoriasis with brodalumab 210 mg in daily practice after 12 and 52 weeks (W). In addition, patient profiles and treatment pathways are described...
April 4, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#25
LETTER
L Bettolini, S Bighetti, S Rovaris, M Arisi, C Romanò, P Calzavara-Pinton, V Maione
No abstract text is available yet for this article.
April 3, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#26
LETTER
Alice Bréhon, Aurore Hamelin, Claire Cariou, Patricia Senet, Gabrielle Sonigo, Tullia De Risi, Annick Barbaud, Emmanuelle Amsler, Angèle Soria
No abstract text is available yet for this article.
April 3, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#27
LETTER
Manuel Sánchez-Díaz, Ángela Hernández-Martín, Miguel Ángel Descalzo, Ignacio García-Doval, Carmen Maria Salavastru
No abstract text is available yet for this article.
April 2, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#28
LETTER
S E B Feldborg, S F Thomsen, C Vestergaard
No abstract text is available yet for this article.
April 2, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#29
JOURNAL ARTICLE
Claudia Zeidler, Sonja Stander, Stephanie Rhoten, Samantha Wratten, Dian Zhang, Jerome Msihid, Ella Brookes, Ryan Thomas, Donia Bahloul
BACKGROUND: Prurigo nodularis (PN) also known as chronic prurigo, is a chronic inflammatory skin disease characterized by intensely itchy nodules/lesions which occur due to intensive scratching. PN management is, in part, based on clinician evaluations of PN lesions, which can be supported by clinician-reported outcomes (ClinRO) such as the Prurigo Activity and Severity (PAS) instrument. A 5-item version of PAS was included in recent phase-3 dupilumab PN trials (PRIME [NCT04183335]/PRIME2 [NCT04202679])...
April 2, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#30
JOURNAL ARTICLE
Nita K F Wienholtz, Casper E Christensen, Håkan Ashina, Niklas R Jørgensen, Alexander Egeberg, Jacob P Thyssen, Messoud Ashina
BACKGROUND: Understanding the role of calcitonin gene-related peptide (CGRP) in the pathogenesis of rosacea might provide new therapeutic avenues for individuals with this disease. OBJECTIVE: To compare plasma levels of CGRP between individuals with rosacea and healthy controls. METHODS: In this cross-sectional case-control study conducted in Copenhagen, Denmark, we collected blood samples from the antecubital vein from adults with rosacea and from healthy controls...
April 1, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#31
LETTER
A Oktem, G L Erkanoglu, B N Akay
No abstract text is available yet for this article.
April 1, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#32
LETTER
A Paradisi, A P Lugli, G Palmisano, G Annessi, A Capponi, C De Simone, K Peris
No abstract text is available yet for this article.
March 30, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#33
LETTER
Ying Li, Xiaoyuan Zhong, Dawei Huang, Yuling Shi, Yangfeng Ding
No abstract text is available yet for this article.
March 30, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#34
LETTER
Tejas P Joshi, T Austin Black, Anthony Duruewuru, Grace N Tisdale, Jennifer Lin, Ritu Sampige, Catherine Seelig, Ciana Sorrels, Haleigh Stafford, Stephanie Trejo Corona, Kritin K Verma, Angela X Wu, Stephanie Zhang, Hannah L Hanania
No abstract text is available yet for this article.
March 30, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#35
LETTER
Thierry Passeron, Brigitte Dreno, Susana Puig, Chee Leok Goh, Hee Young Kang, Fatimata Ly, Akimichi Morita, Jorge Ocampo Candiani, Sergio Schalka, Liu Wei, Anne-Laure Demessant-Flavigny, Caroline Le Floc'h, Delphine Kerob, Henry W Lim, Jean Krutmann
No abstract text is available yet for this article.
March 30, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#36
LETTER
L Gargiulo, L Ibba, P Malagoli, F Amoruso, A Balato, F Bardazzi, M Burlando, C G Carrera, P Dapavo, V Dini, F M Gaiani, G Girolomoni, C Guarneri, C Lasagni, F Loconsole, A V Marzano, M Maurelli, M Megna, M Travaglini, A Costanzo, A Narcisi
No abstract text is available yet for this article.
March 29, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#37
LETTER
A Antelmi, A Metsini, S E Regnell, M Carlberg, Å Svensson, L von Kobyletzki
No abstract text is available yet for this article.
March 29, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#38
LETTER
Sara Al Janahi, Shaden Abdelhadi, Zbigniew Ruszczak
No abstract text is available yet for this article.
March 29, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#39
LETTER
Yuling Zhang, Yueming Mu, Bing Han, Rowida A Albarmaqi, Huimin Wang, Yuemeng Zhao, Zhuang Tian, Jianxin Xia, Shanshan Li, Hong Wang, Aihua Fu, Hua Zheng, Yaping Tian
No abstract text is available yet for this article.
March 28, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
#40
LETTER
Da-Hyun Kang, Myoungsuk Kim, Bark-Lynn Lew, Soon-Hyo Kwon
No abstract text is available yet for this article.
March 28, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
